2-(3-(4-Bromo-2-fluorobenzyl)-4-oxo-3,4-dihydrophthalazin-1-yl)acetic acid, 97%, 100mg

(R)-2-((6-((3-Amino-5-chlorophenyl)amino)-9-isopropyl-9H-purin-2-yl)amino)-3-methylbutan-1-ol, 97%, 10mg

4-Chloro-3-methylbenzotrifluoride, 95.0%, 250mg

Hyperoside, ROTICHROM® Working Standard, 50 mg, emballage en verre

2,4-Dichloro-5-fluorobenzyl bromide, 250mg

TERT-BUTYL 3-(2-(DIMETHYLAMINO)ETHOXY)PROPANOATE, 95.0%, 1g

(S)-3-Aminomethyl-1-N-Cbz-pyrrolidine, 97.0%, 250mg

tert-butyl 2-(4-methoxyphenyl)-7,8-dihydropyrido[3,2-d]pyrimidine-5(6H)-carboxylate, 5mg

(R)-2-(2-Chloro-5-fluorophenyl)pyrrolidine hydrochloride, 97.0%, 100mg

N-methyl-2-pyrrolidin-1-ylethanamine dihydrochloride, 95.0%, 500mg

3-(4-FLUOROPHENYL)-3-HYDROXYPROPANENITRILE, 95%, 5g

(1-tert-butyl-3-pyrrolidinyl)methanol, 95.0%, 250mg

O-(Tetrahydropyran-2-yl)hydroxylamine>98.0%(GC)1g